Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin- cyclophosphamide in early nonresponsive breast cancer: Phase III randomized gepartrio trial

Journal of the National Cancer Institute

Volumn 100, Issue 8, 2008, Pages 542-551

  Von Minckwitz, Gunter ^a,k   Kümmel, Sherko ^b   Vogel, Petra ^c   Hanusch, Claus ^d   Eidtmann, Holger ^e   Hilfrich, Jörn ^f   Gerber, Bernd ^g   Huober, Jens ^h   Costa, Serban Dan ⁱ   Jackisch, Christian ^j   Loibl, Sibylle ^a,k   Mehta, Keyur ^a   Kaufmann, Manfred ^k  

^a German Breast Group   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d Frauenklinik vom Roten Kreuz   (Germany)

^e UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^f Henriettenstiftung   (Germany)

^g ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^j Klinikum Offenbach   (Germany)

^k UNIVERSITY HOSPITAL FRANKFURT   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOCETAXEL; DOXORUBICIN; NAVELBINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; FLUOROURACIL; TAC PROTOCOL; TAXOID; TUMOR MARKER; VINBLASTINE;

ADULT; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER SIZE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; EARLY CANCER; ECHOMAMMOGRAPHY; EDEMA; FEBRILE NEUTROPENIA; FEMALE; FEVER; HAND FOOT AND MOUTH DISEASE; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAIL; NAUSEA; NEUTROPENIA; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SIDE EFFECT; STOMATITIS; THERAPY EFFECT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; BREAST TUMOR; CANCER STAGING; CHEMISTRY; COMPARATIVE STUDY; DRUG ADMINISTRATION; ECHOGRAPHY; GERMANY; LUNG CARCINOMA; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PAGET NIPPLE DISEASE; PATHOLOGY; PROSPECTIVE STUDY; SEGMENTAL MASTECTOMY;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DEOXYCYTIDINE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; GERMANY; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; TAXOIDS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY, MAMMARY; VINBLASTINE;

EID: 43149120682     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn085     Document Type: Article

References (24)

1. Kaufmann M, Hortobagyi GN, Goldhirsch A, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol. 2006;24(12):1940-1949.
2. Bear HD, Anderson S, Smith RE, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 2006;24(13):2019-2027.
3. Beresford MJ, Stott D, Makris A. Assessment of clinical response after two cycles of primary chemotherapy in breast cancer [published online ahead of print July 11, 2007]. Breast Cancer Res Treat. doi:10.1007/s10549-007- 9644-2.
4. von Minckwitz G, Costa SD, Raab G, et al. Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study. J Clin Oncol. 2001;19(15):3506-3515.
5. von Minckwitz G, Sinn HP, Raab G, et al. Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast [NCT00543829]. Breast Cancer Res. In press.
6. Moon YW, Rha SY, Jeung HC, Yang WI, Suh CO, Chung HC. Neoadjuvant chemotherapy with infusional 5-fluorouracil, adriamycin and cyclophosphamide (iFAC) in locally advanced breast cancer: an early response predicts good prognosis. Ann Oncol. 2005;16(11):1778-1785.
7. O'Shaughnessy JA, Blum JL. Capecitabine/taxane combination therapy: evolving clinical utility in breast cancer. Clin Breast Cancer. 2006;7(1):42-50.
8. Seidman AD, O'Shaughnessy J, Misset JL. Single-agent capecitabine: a reference treatment for taxane-pretreated metastatic breast cancer? Oncologist. 2002;7 suppl 6:20-28.
9. Zelek L, Barthier S, Riofrio M, et al. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer. 2001;92(9):2267-2272.
10. von Minckwitz G, Blohmer JU, Raab G, et al. In vivo chemosensitivity- adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Ann Oncol. 2005;16(1):56-63.
11. Sinn HP, Schmid H, Junkermann H, et al. Histological regression of breast cancer after primary (neoadjuvant) chemotherapy [German]. Geburtshilfe Frauenheilkd. 1994;54(10):552-558.
12. von Minckwitz G, Kummel S, du Bois A, et al. Pegfilgrastim {+/-} ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/ cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study. Ann Oncol. 2007;19(2):292-298.
13. von Minckwitz G, Kummel S, Vogel P, et al. Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio Study. J Natl Cancer Inst. 2008;100(8):552-562.
14. http://www.ago-online.de/index.php?site=mamma_guide&lang=de. Accessed October 17, 2007.
15. von Minckwitz G, Raab G, Caputo A, et al. Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group [NCT00543829]. J Clin Oncol. 2005;23(12):2676-2685.
16. Fisher LD. Self-designing clinical trials. Stat Med. 1998;17(14):1551-1562.
17. Martin M, Pienkowski T, Mackey J, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med. 2005;352(22):2302-2313.
18. Verrill MW, Ashley SE, Walsh GA., et al. Royal Marsden Hospital, London. Pathological complete response (pCR) in patients treated with neoadjuvant chemotherapy for operable breast cancer. Breast Cancer Res Treat. 1998;50:Abstract 549.
19. Khayat D, Antoine EC, Nizri d Auclerc G, Lorenzi I. Neoadjuvant chemotherapy in breast cancer: simple prognostic or useful predictive factor? In: ASCO Educational Book. Alexandria, VA: American Society of Clinical Oncology; 2001:510-515.
20. Smith IC, Heys SD, Hutcheon AW, et al. Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol. 2002;20(6):1456-1466.
21. Loibl S, von Minckwitz G, Raab G, et al. Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial. Ann Surg Oncol. 2006;13(11):1434-1442.
22. TNM Classification of Malignant Tumours. 6th ed. Hoboken, NJ: John Wiley & Sons; 2002.
23. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11(3):359-377.
24. AGO Breast Commission, ed. Diagnostic And Treatment of Patients with Primary and Metastatic Breast Cancer. Complete Guidelines of AGO Breast Commission. Munich, Germany; 2008. http://www.ago-online.org/index.php?lang= de&site=mamma_guide_08_1_0&topic=mamma_guide. Accessed March 13, 2008.